small molecules
Partnership formed to expand small-molecule libraries
Provider of label-free drug discovery solutions, SAMDI Tech, has partnered with Enamine — supplier of drug-like screening compounds — to expand the number of molecules in their small-molecule compound libraries. more
Fund manager invests in spin out immune-oncology company NeoPhore
UK based fund manager, Sixth Element Capital, has announced a £3 million investment in a spin out company from PhoreMost — NeoPhore. more
Axxam & Sanofi enter into research collaboration
A research collaboration between Axxam and Sanofi has been announced, which will be aimed at further optimising several small molecules targeted against a range of diseases of the central nervous system (CNS). more
Cambrex announces investment and expansion in Sweden
Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow technology at its Karlskoga facility in Sweden. more
Strategic alliance formed to speed up drug design
Cresset, a provider of software and contract research services for small molecule discovery and design, has signed a three-way strategic agreement to speed up drug design. more
UK firms target small molecule cancer drugs
Phylogica has entered into an agreement with PhoreMost, a biotechnology company, to identify and develop small molecule cancer drugs. more
Bioanalytical Sciences Business to Change Hands
LGC and Quotient Bioresearch are pleased to announce that they have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC. more
